1. Home
  2. RGEN vs CWAN Comparison

RGEN vs CWAN Comparison

Compare RGEN & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.25

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Clearwater Analytics Holdings Inc.

CWAN

Clearwater Analytics Holdings Inc.

HOLD

Current Price

$22.41

Market Cap

5.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
CWAN
Founded
1981
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
5.3B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RGEN
CWAN
Price
$162.25
$22.41
Analyst Decision
Buy
Strong Buy
Analyst Count
10
9
Target Price
$174.90
$30.67
AVG Volume (30 Days)
701.7K
5.8M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
46826.67
EPS
0.03
1.40
Revenue
$707,890,000.00
$640,376,000.00
Revenue This Year
$17.84
$64.92
Revenue Next Year
$12.57
$29.34
P/E Ratio
$5,259.20
$15.88
Revenue Growth
11.74
50.91
52 Week Low
$102.97
$15.74
52 Week High
$182.52
$32.00

Technical Indicators

Market Signals
Indicator
RGEN
CWAN
Relative Strength Index (RSI) 54.15 63.83
Support Level $156.01 $21.14
Resistance Level $165.02 $22.14
Average True Range (ATR) 4.65 0.73
MACD -1.07 -0.05
Stochastic Oscillator 43.33 91.17

Price Performance

Historical Comparison
RGEN
CWAN

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CWAN Clearwater Analytics Holdings Inc.

Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.

Share on Social Networks: